RADTHYR: an open-label, single-arm, prospective multicenter phase II trial of Radium-223 for the treatment of bone metastases from radioactive iodine refractory differentiated thyroid cancer
Titel:
RADTHYR: an open-label, single-arm, prospective multicenter phase II trial of Radium-223 for the treatment of bone metastases from radioactive iodine refractory differentiated thyroid cancer
Auteur:
Deandreis, Désirée Maillard, Aline Zerdoud, Slimane Bournaud, Claire Vija, Lavinia Sajous, Christophe Terroir, Marie Leenhardt, Laurence Schlumberger, Martin Borget, Isabelle Leboulleux, Sophie
Verschenen in:
European journal of nuclear medicine and molecular imaging